|
Sign In to gain access to subscriptions and/or personal tools.
|
Human Neutrophil Collagenase MMP-8 in Peri-implant Sulcus Fluid and its Inhibition by Clodronate
O. Teronen
Department of Oral and Maxillofacial Surgery, Institute of Dentistry, P.O. Box 41, FIN-00014 University of Helsinki, Finland, Department of Oral and Maxillofacial Surgery, Department of Surgery, University of Helsinki
Y.T. Konttinen
Department of Medicine and Department of Anatomy, University of Helsinki
C. Lindqvist
Department of Oral and Maxillofacial Surgery, Institute of Dentistry, P.O. Box 41, FIN-00014 University of Helsinki, Finland, Department of Oral and Maxillofacial Surgery, Department of Surgery, University of Helsinki
T. Salo
Departments of Oral and Maxillofacial Surgery and Pathology, University of Oulu
T. Ingman
Department of Pedodontics and Orthodontics, Institute of Dentistry, University of Helsinki
A. Lauhio
Department of Medical Chemistry, University of Helsinki
Y. Ding
Department of Periodontology, Institute of Dentistry, University of Helsinki
S. Santavirta
Department of Orthopedics and Traumatology, Department of Surgery, University of Helsinki
T. Sorsa
Department of Periodontology, Institute of Dentistry, University of Helsinki, Department of Medical Chemistry, University of Helsinki
The exact molecular mechanisms of the loosening of a dental implant are not well-known. The characteristics of implant sulci are similar to those of periodontal sulci regarding gingival crevicular fluid (GCF) and peri-implant sulcular fluid (PISF). Proteolytic enzymes, matrix metalloproteinases (MMPs), participate in peri-implant tissue remodeling. Clodronate is a well-tolerated bisphosphonate-group drug currently used in bone-resorption-related diseases in humans. The mechanisms of bisphosphonate action are not clarified. Collagenase activity in diseased PISF was significantly higher than in the clinically healthy group. Immunoblotting disclosed that diseased PISF contained increased immunoreactives MMP-8 compared with the healthy PISF. The residual latent collagenase activity in the diseased PISF was activated by gold thioglucose and inhibited completely by 100 pM of doxycycline closely resembling pure neutrophil collagenase (MMP-8). The presence of MMP-8 in diseased but not in clinically healthy PISF may prove to be a useful biochemical indicator to monitor peri-implant health and disease. Pure human neutrophil collagenase (MMP-8) and the MMP-8 present in PISF and in the GCF of both loosening implants and periodontitis-affected teeth were efficiently inhibited in vitro by clodronate (50% inhibition [IC50] was achieved by 150 uM of clodronate), an osteoactive, antiresorptive bisphosphonate. Furthermore, the new finding suggests an extended and hitherto-undescribed potential for clodronate in preventing the loosening of both implants and teeth, based on a dual beneficial effect: prevention of both bone resorption/osteolysis and of soft tissue/dental ligament destruction. Potential new therapeutic indications based on the collagenase-inhibiting effect of clodronate provide potential new therapeutic indications for a variety of diseases involving connective tissue breakdown, such as periodontal disease, arthritides, and tumor invasion.
Key Words: metalloproteinases clodronate/bisphosphonates inhibition gingival crevicular fluid peri-implant sulcus fluid.
REFERENCES
- Ainamo J., Barmes D., Beagrie G., Cutress T., Martin J., Sardo-Infirri J. (1982). Development of the World Health Organization (WHO) community periodontal index of treatment needs (CPITN). Int Dent J 32:281-291.[Medline]
[Order article via Infotrieve]
- Apse P., Ellen RP, Overall CM, Zarb GA ( 1989). Microbiota and crevicular fluid collagenase activity in the osteointegrated dental implant sulcus: A comparison of sites in edentulous and partially edentulous patients. J Periodont Res 24:96-105.[CrossRef][Medline]
[Order article via Infotrieve]
- Brånemark PI (1985). Introduction to osseointegration. In: Tissue integrated prostheses, osseointegration in clinical dentistry. Zarb GA, Albrektsson T, editors. Chicago: Quintessence Publishing Company Inc., pp. 11-76.
- Birkedal-Hansen H., Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B., DeCarlo A., et al. (1993). Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4:197-250.[Abstract/Free Full Text]
- Brunsvold MA, Chaves ES, Kornman KS, Aufdemorte TB, Wood R. ( 1992). Effects of a bisphosphonate on experimental periodontitis in monkeys. J Periodontol 63:825-830.[Medline]
[Order article via Infotrieve]
- Chubinskaya S., Huch K., Mikecz K., Cs-Szabo G., Hasty KA, Kuettner KE, et al. (1996). Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1 beta in human cartilage from knee and ankle joints. Lab Invest 74:232-240.[Medline]
[Order article via Infotrieve]
- DeCarlo A. Jr (1994). Matrix metalloproteinase activation and induction in keratinocytes by a purified thiol-proteinase from Porphyromonas gingivalis (PhD thesis/dissertation). Birmingham, AL: University of Alabama, pp. 1-79.
- Evanson JM, Jeffrey JJ, Krane SM (1967). Human collagenase: identification and characterization of an enzyme from rheumatoid synovium in culture. Science 158:499-502.[Abstract/Free Full Text]
- Fleisch H. (1991). Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease. Drugs 42:919-944.[Medline]
[Order article via Infotrieve]
- Frost HM (1983). In: Bone histomorphometry: Techniques and interpretation. Reckker RR, editor. Boca Raton, FL: CRC Press, pp. 109-123.
- Fosang AJ, Last K., Neame PJ, Murphy G., Knauper V., Tschesche H., et al. (1994). Neutrophil collagenase (MMP-8) cleaves at the aggrecanase site E373-A374 in the interglobular domain of cartilage aggrecan. Biochem J 304:347-351.[Medline]
[Order article via Infotrieve]
- Fosang AJ, Last K., Knauper V., Murphy G., Neame PJ (1996). Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett 380:17-20.[CrossRef][Medline]
[Order article via Infotrieve]
- Fullmer HM, Gibson WA, Lazarus GS, Bladen HA, Whedon KA (1969). The origin of collagenase in periodontal tissues of man. J Dent Res 48:646-651.
- Gangbar S., Overall CM, McCulloch CA, Sodek J. (1990). Identification of polymorphonuclear leukocyte collagenase and gelatinase activities in mouthrinse samples: correlation with periodontal disease activity in adult and juvenile periodontitis. J Periodont Res 25:257-267.[CrossRef][Medline]
[Order article via Infotrieve]
- Goldberg GI, Wilhelm SM, Kronberger A., Bauer EA, Grant GA, Eisen AZ (1986). Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. J Biol Chem 261:6600-6605.[Abstract/Free Full Text]
- Golub LM, Ciancio S., Ramamurthy NS, Leung M., McNamara TF (1990). Low-dose doxycycline therapy: effect on gingival and crevicular fluid collagenase activity in humans. J Periodont Res 25:321-330.[CrossRef][Medline]
[Order article via Infotrieve]
- Golub LM, Suomalainen K., Sorsa T. (1992). Host modulation with tetracyclines and their chemically modified analogues. Curr Opin Dent 2:80-90.[Medline]
[Order article via Infotrieve]
- Golub LM, Sorsa T., Lee HM, Ciancio S., Sorbi D., Ramamurthy NS, et al. (1995). Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva. J Clin Periodontol 22:100-109.[Medline]
[Order article via Infotrieve]
- Greenwald RA, Golub LM, Lavietes B., Ramamurthy NS, Gruber B., Laskin RS, et al. (1987). Tetracyclines inhibit human synovial collagenase in vivo and in vitro. J Rheumatol 14:28-32.[Medline]
[Order article via Infotrieve]
- Greenwald RA, Moak SA, Ramamurthy NS, Golub LM (1992). Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage. J Rheumatol 19:927-938.[Medline]
[Order article via Infotrieve]
- Harris ED Jr, DiBona DR, Krane SM (1969). Collagenase in synovial fluid. J Clin Invest 48:2104-2113.[Medline]
[Order article via Infotrieve]
- Igarashi K., Adachi H., Mitani H., Shinoda H. (1996). Inhibitory effect of the topical administration of a bisphosphonate (risedronate) on root resorption incident to orthodontic tooth movement in rats. J Dent Res 75:1644-1649.
- Ingman T., Kononen M., Konttinen YT, Ylipaavalniemi P., Ding Y., Tervahartiala T., et al. (1994). Proteolytic enzymes in sulcular fluid of osseointegrated dental implant patients in comparison to periodontitis patients and healthy control subjects. In: Biological mechanisms of tooth eruption, resorption and replacement by implants. Davidovitch Z, editor. Boston, MA: Harvard Society for the Advancement of Orthodontics, pp. 681-686.
- Ingman T., Tervahartiala T., Ding Y., Tschesche H., Haerian A., Kinane DF, et al. (1996). Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients. J Clin Periodontol 23:1127-1132.[CrossRef][Medline]
[Order article via Infotrieve]
- Jeffcoat MK, Reddy MS (1996). Alveolar bone loss and osteoporosis: Evidence for a common mode of therapy using the bisphosphonate alendronate. In: Biological mechanisms of tooth movement and craniofacial adaptation. Davidovitch Z, Norton LA, editors. Boston, MA: Harvard Society for the Advancement of Orthodontics, pp. 365-373.
- Konttinen YT, Lindy 0, Kemppinen P., Saari H., Suomalainen K., Vauhkonen M., et al. (1991). Collagenase reserves in polymorphonuclear leukocytes from synovial fluid and peripheral blood of patients with rheumatoid arthritis. Matrix 11:296-301.[Medline]
[Order article via Infotrieve]
- Lauhio A., Sorsa T., Lindy 0, Suomalainen K., Saari H., Golub LM, et al. (1992). The anticollagenolytic potential of lymecycline in the treatment of reactive arthritis. Arthrit Rheum 35:195-198.[Medline]
[Order article via Infotrieve]
- Lauhio A., Konttinen YT, Tschesche H., Nordstrom D., Salo T., Lahdevirta J., et al. (1994a). Reduction of matrix metalloproteinase 8-neutrophil collagenase levels during long-term doxycycline treatment. Antimicrob Agents Chemother 38:400-402.[Abstract/Free Full Text]
- Lauhio A., Salo T., Ding Y., Konttinen YT, Nordstrom D., Tschesche H., et al. (1994b). In vivo inhibition of human neutrophil collagenase (MMP-8) activity during long-term combination therapy of doxycycline and non-steroidal anti-inflammatory drugs (NSAID) in acute reactive arthritis. Clin Exp Immunol 98:21-28.[Medline]
[Order article via Infotrieve]
- Lauhio A., Salo T., Tjaderhane L., Lahdevirta J., Golub LM, Sorsa T. (1995). Tetracyclines in treatment of rheumatoid arthritis. Lancet 346:645-646.[Medline]
[Order article via Infotrieve]
- Michaelis J., Vissers MC, Winterbourn CC (1990). Human neutrophil collagenase cleaves
1-antitrypsin. Biochem J 270:809-814.[Medline]
[Order article via Infotrieve] - Overall CM, Sodek J., McCulloch CA, Birek P. (1991). Evidence for polymorphonuclear leukocyte collagenase and 92-kilodalton gelatinase in gingival crevicular fluid. Infect Immun 59:4687-4692.[Abstract/Free Full Text]
- Reddy MS, Weatherford TW 3rd, Smith CA, West BD, Jeffcoat MK, Jacks TM (1995). Alendronate treatment of naturally occurring periodontitis in beagle dogs. J Periodontol 66:211-217.[Medline]
[Order article via Infotrieve]
- Salo T., Kylmaniemi M., Helaakoski T., Virkkunen J., Ding Y., Konttinen YT, et al. (1995). MMP-8/neutrophil collagenase mRNA may also be expressed in other cells than PMNs (abstract). J Dent Res 74(Spec Iss):1036.
- Santavirta S., Sorsa T., Konttinen YT, Saari H., Eskola A., Eisen ZA (1993). Role of mesenchymal collagenase in the loosening of total hip prosthesis. Clin Orthop Rel Res 290:206-215.[Medline]
[Order article via Infotrieve]
- Sato M., Grasser W., Endo N., Akins R., Simmons H., Thompson DD, et al. (1991). Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest 88:2095-2105.[Medline]
[Order article via Infotrieve]
- Sorsa T. (1989). Human leukocyte collagenase: purification, activation and its role in periodontal collagen degradation (PhD thesis/dissertation). Helsinki, Finland: University of Helsinki, pp. 1-62.
- Sorsa T., Uitto V.-J, Suomalainen K., Vauhkonen M., Lindy S. (1988). Comparison of interstitial collagenases from human gingiva, sulcular fluid and polymorphonuclear leukocytes. J Periodont Res 23:386-393.[CrossRef][Medline]
[Order article via Infotrieve]
- Sorsa T., Ding Y., Salo T., Lauhio A., Teronen 0, Ingman T., et al. (1994). Effects of tetracyclines on neutrophil, gingival, and salivary collagenases. A functional and Western-blot assessment with special reference to their cellular sources in periodontal diseases. Ann NY Acad Sci 732:112-131.[Medline]
[Order article via Infotrieve]
- Sorsa T., Lukinmaa P-L., Westerlund U., Ingman T., Ding Y., Tschesche H., et al. (1996). The expression, activation, and chemotherapeutic inhibition of matrix metalloproteinase-8 (neutrophil collagenase/collagenase-2) in inflammation. In: Biological mechanisms of tooth eruption, resorption and replacement by implants. Davidovitch Z, editor. Boston, MA: Harvard Society for the Advancement of Orthodontics, pp. 317-323.
- Sorsa T., Salo T., Koivunen E., Tyynela J., Teronen 0, Heikkila P., et al. (1997). Activation of progelatinases by human tumor-associated trypsin-2. J Biol Chem (in press).
- Suomalainen K., Sorsa T., Golub LM, Ramamurthy N., Lee H-M., Uitto V-J., et al. (1992). Specificity of the anti-collagenase action of tetracyclines: relevance to their anti-inflammatory potential. Antimicrob Agents Chemother 36:227-229.[Abstract/Free Full Text]
- Takagi M., Santavirta S., Konttinen YT, Lindy 0, Sorsa T., Kurvinen H., et al. (1994a). Proteolytic potential of matrix metalloproteinases and serine proteinases in the host response to THR endoprosthesis. Bioceramics 7:311-316.
- Takagi M., Konttinen YT, Santavirta S., Sorsa T., Eisen AZ, Nordsletten L., et al. (1994b). Extracellular matrix metalloproteinases around loose total hip prostheses. Acta Orthop Scand 65:281-286.[Medline]
[Order article via Infotrieve]
- Teronen 0, Salo T., Laitinen J., Törnwall J., Ylipaavalniemi P., Konttinen YT, et al. (1995). Characterization of interstitial collagenases in jaw cyst walls. Eur J Oral Sci 103:141-147.[Medline]
[Order article via Infotrieve]
- Teronen 0, Husa V., Lindqvist C., López-Òtin C., Salo T., Konttinen YT, et al. (1997a). MMP-13 in peri-implant sulcus fluid (PISF) of different patient groups (abstract). J Dent Res 76(Spec Iss):144.
- Teronen 0, Konttinen YT, Lindqvist C., Salo T., Ingman T., Lauhio A., et al. (1997b). Inhibition of matrix metalloproteinase-1 by dichloromethylene bisphosphonate (clodronate). Calcif Tissue Int (in press).
- Teronen 0, Sorsa T., Salo T. ( 1997c). Inhibition of the degradation of connective tissue matrix protein components in mammals. US Patent 5,652,227.
- Tonetti MS, Freiburghaus K., Lang NP, Bickel M. (1993). Detection of interleukin-8 and matrix metalloproteinases transcripts in healthy and diseased gingival biopsies by RNA/PCR. J Periodont Res 28:511-513.[CrossRef][Medline]
[Order article via Infotrieve]
- Turto H., Lindy S., Uitto VJ, Wegelius 0, Uitto J. (1977). Human leukocyte collagenase: characterization of enzyme kinetics by a new method. Anal Biochem 83:557-569.[CrossRef][Medline]
[Order article via Infotrieve]
- Weiss SJ (1989). Tissue destruction by neutrophils. N Engl J Med 320:365-376.[Medline]
[Order article via Infotrieve]
- Westerlund U., Ingman T., Lukinmaa P-L., Salo T., Kjeldsen L., Borregaard N., et al. (1996). Human neutrophil gelatinase and associated lipocalin in adult and localized juvenile periodontitis. J Dent Res 75:1553-1563.
- Woessner JF Jr (1991). Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145-2154.[Abstract]
- Yu LP Jr, Smith GN Jr, Brandt KD, Myers SL, O'Connor BL, Brandt DA (1992). Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline. Arthrit Rheum 35:1150-1159.[Medline]
[Order article via Infotrieve]
Journal of Dental Research, Vol. 76, No. 9,
1529-1537 (1997)
DOI: 10.1177/00220345970760090401

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Gendron, D. Grenier, T. Sorsa, and D. Mayrand
Inhibition of the Activities of Matrix Metalloproteinases 2, 8, and 9 by Chlorhexidine
Clin. Vaccine Immunol.,
May 1, 1999;
6(3):
437 - 439.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|